Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease

被引:1
|
作者
Quintero-Puerta, Teresa [1 ]
Lira-Lucio, Juan Alberto [1 ]
Falfan-Valencia, Ramces [1 ]
Vega-Sanchez, Angel E. [2 ]
Marquez-Garcia, Eduardo [3 ]
Mejia, Mayra [2 ]
Bautista-Becerril, Brandon [1 ]
Rojas-Serrano, Jorge [2 ]
Ramos-Martinez, Espiridion [4 ]
Buendia-Roldan, Ivette [5 ]
Perez-Rubio, Gloria [1 ]
机构
[1] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, HLA Lab, Mexico City, Mexico
[2] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Interstitial Lung Dis & Rheumatol Unit, Mexico City, Mexico
[3] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Subdirecc Invest Biomed, Mexico City, Mexico
[4] Univ Nacl Autonoma Mexico, Fac Med, Expt Med Res Unit, Mexico City, Mexico
[5] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Translat Res Aging & Pulm, Mexico City, Mexico
关键词
lung microbiome; 16S ribosomal subunit; antisynthetase syndrome; interstitial lung disease; Veillonella; CHAIN FATTY-ACIDS; CLINICAL-FEATURES; FIBROSIS; COHORT;
D O I
10.3389/fcimb.2023.1321315
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Aim: To characterize the lung microbiome in the bronchoalveolar lavage fluid (BALF) of patients with Antisynthetase Syndrome (ASSD) according to anti-Jo1 autoantibody positivity and evaluate the correlation with differential cell count and other bacterial genera in BALF.Methods: We sequenced the 16S ribosomal RNA gene in the BALF of anti-Jo1-positive (JoP, n=6) and non-Jo1-positive (NJo, n=17) patients, and the differential cell count in BALF was evaluated. The Spearman's correlation was calculated for the quantitative variables and abundance of bacterial species.Results: The Veillonella genus showed a significant decrease (p<0.01) in JoP (2.2%) in comparison to NJo (4.1%) patients. The correlation analysis showed several high (rho >= +/- 0.7) and significant (p < 0.05) correlations. We analyzed the results obtained for the Veillonella genera and other study variables. The JoP group showed that the abundance of Veillonella had a high negative correlation with macrophages (rho = - 0.77) and a positive correlation with eosinophils (rho = 0.77), lymphocytes (rho = 0.77), and Prevotella (rho = 1).Conclusions: The lung microbiome in ASSD patients differs and may affect cell composition, contributing to lung damage mechanisms. The presence of anti-Jo1 autoantibodies showed a low abundance of Veillonella. This genus had a strong and positive correlation with Prevotella abundance and levels of eosinophils and lymphocytes, and it showed a strong negative correlation with the percentage of macrophages.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] INTERSTITIAL LUNG DISEASE IN PATIENTS WITH ANTISYNTHETASE SYNDROME AND ANTI-RO52 ANTIBODIES POSITIVE
    Aguilera Gros, C.
    Ruiz Roman, A.
    Mendez Diaz, L.
    Morote Ibarrola, G.
    Garrido Punal, N.
    Arcila Duran, M.
    Montes Cano, M. A.
    Rodriguez Portal, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 505 - 505
  • [22] Diffuse Interstitial Lung Disease Revealing Antisynthetase Syndrome
    Benjelloun, Hanane
    Haouassia, Fatima Ezzahra
    Chaanoune, Khadija
    Zaghba, Nahid
    Yassine, Najiba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [23] CASE OF REFRACTORY INTERSTITIAL LUNG DISEASE IN ANTISYNTHETASE SYNDROME
    Hussein, Abdirahman
    Espinosa, Ronald
    Chittivelu, Subramanyam
    CHEST, 2020, 158 (04) : 2606A - 2606A
  • [24] Antisynthetase syndrome and interstitial lung disease: A case report
    Dahal, Krishna
    Chaudhary, Anand
    Rawal, Laba
    Ray, Umesh
    Paudel, Sandip
    Khanal, Pitambar
    Gyawali, Pawan
    Sah, Sanjit Kumar
    Shrestha, Kishan Kumar
    Pandey, Shailendra
    ANNALS OF MEDICINE AND SURGERY, 2022, 82
  • [25] Interstitial lung disease in a patient with antisynthetase syndrome and no myositis
    Plastiras, Sotiris C.
    Soliotis, Fotini C.
    Vlachoyiannopoulos, Panayiotis
    Tzelepis, George E.
    CLINICAL RHEUMATOLOGY, 2007, 26 (01) : 108 - 111
  • [26] Acute interstitial lung disease revealing antisynthetase syndrome
    Bizien, N.
    Renault, A.
    Boles, J. -M.
    Delluc, A.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2011, 67 (06) : 367 - 370
  • [27] Interstitial lung disease in a patient with antisynthetase syndrome and no myositis
    Sotiris C. Plastiras
    Fotini C. Soliotis
    Panayiotis Vlachoyiannopoulos
    George E. Tzelepis
    Clinical Rheumatology, 2007, 26 : 108 - 111
  • [28] INTERSTITIAL LUNG DISEASE AS A FIRST MANIFESTATION OF THE ANTISYNTHETASE SYNDROME
    Desai, Pankil
    Gupta, Kimberly
    Moniodis, Anna
    Bernstein, Michael
    CHEST, 2018, 154 (04) : 441A - 441A
  • [29] ANTISYNTHETASE SYNDROME: A RARE CAUSE OF INTERSTITIAL LUNG DISEASE
    Habib, Muhammad
    Zheng, Danyi
    Goldstein, Alexander
    Mohammedzein, Assad
    Thien Vo
    Patel, Manish
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S465 - S465
  • [30] Antisynthetase Syndrome with Anti-Jo1 Antibodies in 48 Patients: Pulmonary Involvement Predicts Disease-modifying Antirheumatic Drug Use
    Stanciu, Raluca
    Guiguet, Marguerite
    Musset, Lucile
    Touitou, Diane
    Beigelman, Catherine
    Rigolet, Aude
    Costedoat-Chalumeau, Nathalie
    Allenbach, Yves
    Hervier, Baptiste
    Dubourg, Odile
    Maisonobe, Thierry
    Charuel, Jean-Luc
    Behin, Anthony
    Herson, Serge
    Amoura, Zahir
    Grenier, Philippe
    Benveniste, Olivier
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (09) : 1835 - 1839